A single-center retrospective study evaluating Gadobenate dimeglumine enhanced biliary magnetic resonance imaging in patients from the hepatobiliary phase in predicting hepatic decompensation and insufficiency for patients with liver cirrhosis
Latest Information Update: 30 Jul 2021
At a glance
- Drugs Gadobenic acid (Primary)
- Indications Liver cirrhosis
- Focus Adverse reactions
- 01 Aug 2021 Results published in the European Radiology
- 30 Jul 2021 New trial record